Cargando...
Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
The development of oncolytic viruses (OVs) has increased significantly in the past 20 years, with many candidates entering clinical trials and three of them receiving approval for some indications. Recently, OVs have also gathered interest as candidates to use in combination with immunotherapies for...
Guardado en:
| Publicado en: | J Immunother Cancer |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871674/ https://ncbi.nlm.nih.gov/pubmed/33558278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001684 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|